Encapsulate

Overview

Encapsulate. Encapsulate develops automated tumor-on-a-chip systems that functionally test how each patient's cancer responds to treatment. We screen patient-derived microtumors against clinical treatment regimens to deliver personalized response profiles in under 7 days.

Funding and backers

Team
11-50
employees, estimated range
Grants
$2.5M
4 grants · CORDIS
Backers
1
BioTools Innovator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 15, 2025 Won a grant $900k · CORDIS Jun 5, 2025 Won a grant $1.2M · CORDIS Aug 7, 2024 Won a grant $156k · CORDIS May 15, 2022 Won a grant $256k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Jul 2025 $900k — CORDIS
Grant Jun 2025 $1.2M — CORDIS
Grant Aug 2024 $156k — CORDIS
Grant May 2022 $256k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
BioTools Innovator fund
Investors in similar startupsfunds that back the companies most like this one
Hub71
backs VivanTX
SFC Capital
backs VivanTX
Bayern Kapital
backs 4screen
AIX Ventures
backs Alphabiome
IncubAlliance
backs IterOnco
Sharrp Ventures
backs Cure Skin
Similar startupsby what they do, their industry and backers
VivanTXVenture round · 1 mo ago · Founded 2018 · 11-50 employees
You deserve personalized cancer treatment. We enable it.
Alphabiome1-10 employees
Alphabiome builds the biological intelligence layer for AI, reading raw bacterial, viral, fungal, and host DNA to predict how patients…
Prevision MedicineSeed $5.4M · 1 mo ago · 51-200 employees
By testing the response of a patient’s own cancer cells against many treatment options, we help physicians and patients make truly informed…
IterOncoFounded 2024 · 1-10 employees
Opening Tumors to Treatment. Founded in 2024 by Dr. Manale Karam after 16 years of international cancer research, driven by the conviction…
Cure SkinFounded 2017 · 51-200 employees
Get free AI analysis and dermatologist-prescribed regimens to treat your skin & hair concerns. Holistic, safe & 100% effective. Learn more.
okomeraFounded 2020
Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma…

Financials

Total raised
$2.5M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2025 $900k Details
Grant 2025 $1.2M Details
Grant 2024 $156k Details
Grant 2022 $256k Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
BioTools InnovatorVia a fund
39 portfolio companies: EpiPaws</a> (Copy), Eukarys, Innovator and 36 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Farmington United States
HQ
400 Farmington Ave., R1841, Farmington, CT 06032
10-50 est. staff
400 Farmington Ave., R1841 Farmington, CT 06032
company site